Safety of the Hepatitis B Vaccine
- 7 February 1985
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 312 (6), 375-376
- https://doi.org/10.1056/nejm198502073120613
Abstract
To the Editor: Since the identification of the acquired immunodeficiency syndrome (AIDS) in sexually active homosexual men, questions have arisen regarding the possibility that an agent for AIDS may be transmissible through plasma-derived vaccines for hepatitis B virus. Epidemiologic data on vaccine recipients do not support this possibility. Nevertheless, as mentioned Jacobson et al. (Oct. 18 issue),1 this concern has affected vaccine use by people who should be immunized.2 Human T-cell lymphotropic virus III (HTLV-III) was recently isolated in a high proportion of cases of AIDS, and antibody to HTLV-III has been detected in nearly all cases, suggesting that HTLV-III . . .Keywords
This publication has 7 references indexed in Scilit:
- Lack of Effect of Hepatitis B Vaccine on T-Cell PhenotypesNew England Journal of Medicine, 1984
- Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of EfficacyAnnals of Internal Medicine, 1984
- SEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROMEThe Lancet, 1984
- Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSScience, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- No Increased Incidence of AIDS in Recipients of Hepatitis B VaccineNew England Journal of Medicine, 1983
- Hepatitis B VaccineNew England Journal of Medicine, 1980